New Jersey Startup Launches With Clinical Assets From Big Name Biotechs Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry<… Source: BioSpace You Might Also Like Money Problems Push SoCal's ImmunoCellular To Suspend Trial, Seek Strategic Alternatives June 20, 2017 Lilly Exploring Strategic Alternatives for Animal Health Biz January 31, 2018 Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride September 10, 2017
Money Problems Push SoCal's ImmunoCellular To Suspend Trial, Seek Strategic Alternatives June 20, 2017
